A sourcing study to collect human blood samples from healthy adults

Trial Identifier: 207911
Sponsor: GlaxoSmithKline
Start Date: March 2018
Primary Completion Date: May 2022
Study Completion Date: May 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Australia, New South Wales Sydney, New South Wales, Australia, 2010
Australia, South Australia Adelaide, South Australia, Australia, 5000
Australia, Victoria Geelong, Victoria, Australia, 3220
Australia, Victoria Melbourne, Victoria, Australia, 3004
Australia, Western Australia Spearwood, Western Australia, Australia, 6163
Germany, Bayern Wuerzburg, Bayern, Germany, 97070